Cracking the Code of Coronary Calcium: One-year Clinical Outcomes of Intravascular Lithotripsy in All-comers and Two Complex Cohorts
Open Access
- 3 July 2024
- journal article
- research article
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 3
Abstract
Background: Severe coronary calcifications are commonly encountered in real-world populations and in left main (LM) disease, heightening complication risks including stent underexpansion. Although intravascular lithotripsy (IVL) appears safe, longer-term data in high-risk populations are lacking. The aim of this study was therefore to examine 1-year IVL outcomes for severely calcified lesions in two complex cohorts: LM stenosis and underexpanded stents (UES) during stent implantation. Methods: A registry study was carried out to examine major adverse cardiovascular events (MACEs) (MI, target vessel revascularisation [TVR], cardiac mortality). The LM and UES subgroups were compared with their counterparts in the non-LM and de novo lesion subgroups, respectively. Results: The study involved 102 participants (median age, 70 years, 68% male), and the cardiovascular burden was high (diabetes, 72%; dialysis, 18%; prior MI, 43%, median left ventricular ejection fraction, 45%). Many participants presented acutely (acute coronary syndrome, 36%; decompensated heart failure, 13%) and had complex anatomies (triple-vessel disease, 77%). The cardiovascular burden was higher in the LM and UES subgroups than in the non-LM and de novo lesion subgroups, but the rates of procedural complications and 30-day MACEs were low and were not significantly different. The 1-year MACE rate was higher in the LM group than in non-LM (29% versus 10%, p=0.042), but was non-significant after adjusting for baseline variables (OR 3.08; 95% CI [0.87–10.9]); the rates of 1-year MI, TVR and mortality did not differ from non-LM. In the UES group, 1-year MACE rate (17% versus 13%, p=0.500) was similar to that for de novo lesions. Conclusion: The preliminary data suggest that the use of IVL is reasonable when encountering stent underexpansion due to severe coronary calcifications during stent implantation. The 1-year MACE rate was higher in calcific LM stenosis, probably due to greater comorbidity burden and acute presentations.Keywords
This publication has 27 references indexed in Scilit:
- Atherectomy debulking of calcified left main coronary lesions: strategies and technologies2022
- Principles of Intravascular Lithotripsy for Calcific Plaque ModificationJACC: Cardiovascular Interventions, 2021
- Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery DiseaseJACC, 2020
- One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registryClinical Research in Cardiology, 2019
- “Balloon-Uncrossable” and “Balloon-Undilatable” Chronic Total Occlusions2018
- Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer‐generation DES: Findings from a large multiethnic registryCatheterization and Cardiovascular Interventions, 2017
- Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney DiseaseJAMA Cardiology, 2017
- Orbital Atherectomy for Treating De Novo Severely Calcified Coronary Narrowing (1-Year Results from the Pivotal ORBIT II Trial)The American Journal of Cardiology, 2015
- Current Status of Rotational AtherectomyJACC: Cardiovascular Interventions, 2014
- High-Speed Rotational Atherectomy Before Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary LesionsJACC: Cardiovascular Interventions, 2013